MapLight Therapeutics Funding & Investors

Palo Alto, CA

Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).

Total Amount Raised: $268,100,000

MapLight Therapeutics Funding Rounds

Series C
$225,000,000
Oct 29, 2023
Series C Investors
5am Ventures
Cowen
Novo Holdings
Series Unknown
$29,999,999
Mar 9, 2021
Grant
$8,100,000
Nov 29, 2020
Grant Investors
The Michael J. Fox Foundation for Parkinson's Research
Series Unknown
$5,000,000
Mar 7, 2019

Funding info provided by Diffbot.